These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20812769)

  • 21. [Emergent adverse effects of proton pump inhibitors].
    Bourne C; Charpiat B; Charhon N; Bertin C; Gouraud A; Mouchoux C; Skalli S; Janoly-Dumenil A
    Presse Med; 2013 Feb; 42(2):e53-62. PubMed ID: 23237784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of proton pump inhibitors and risk of osteoporosis-related fractures.
    Targownik LE; Lix LM; Metge CJ; Prior HJ; Leung S; Leslie WD
    CMAJ; 2008 Aug; 179(4):319-26. PubMed ID: 18695179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acid-suppressive medications and risk of bone loss and fracture in older adults.
    Yu EW; Blackwell T; Ensrud KE; Hillier TA; Lane NE; Orwoll E; Bauer DC
    Calcif Tissue Int; 2008 Oct; 83(4):251-9. PubMed ID: 18813868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton pump inhibitors and fracture: they impair bone quality and increase fall risk?
    Sugiyama T; Watarai K; Oda T; Kim YT; Oda H
    Osteoporos Int; 2016 Apr; 27(4):1675-1676. PubMed ID: 26860500
    [No Abstract]   [Full Text] [Related]  

  • 25. [Do opioids, sedatives and proton-pump inhibitors increase the risk of fractures?].
    Thorsdottir G; Benedikz E; Thorgeirsdottir SA; Johannsson M
    Laeknabladid; 2017 Mai; 103(5):231-235. PubMed ID: 28489008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton Pump Inhibitors and Fracture Risk: A Review of Current Evidence and Mechanisms Involved.
    Thong BKS; Ima-Nirwana S; Chin KY
    Int J Environ Res Public Health; 2019 May; 16(9):. PubMed ID: 31060319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium.
    Ito T; Jensen RT
    Curr Gastroenterol Rep; 2010 Dec; 12(6):448-57. PubMed ID: 20882439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between proton pump inhibitors use and risk of hip fracture: A general population-based cohort study.
    Wei J; Chan AT; Zeng C; Bai X; Lu N; Lei G; Zhang Y
    Bone; 2020 Oct; 139():115502. PubMed ID: 32593677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPIs and fracture risk.
    Med Lett Drugs Ther; 2013 Feb; 55(1410):15-6. PubMed ID: 23459458
    [No Abstract]   [Full Text] [Related]  

  • 30. Proton Pump Inhibitors, But Not H2-receptor Antagonists, Are Associated With Incident Fractures Among Kidney Transplant Recipients.
    Lyu B; Jorgenson MR; Hansen KE; Djamali A; Astor BC
    Transplantation; 2020 Dec; 104(12):2609-2615. PubMed ID: 32058466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of the association between hip fracture and acid-suppressive drug use in a UK primary care setting.
    Cea Soriano L; Ruigómez A; Johansson S; García Rodríguez LA
    Pharmacotherapy; 2014 Jun; 34(6):570-81. PubMed ID: 24634193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton-pump inhibitors and risk of fractures: an update meta-analysis.
    Zhou B; Huang Y; Li H; Sun W; Liu J
    Osteoporos Int; 2016 Jan; 27(1):339-47. PubMed ID: 26462494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: a prospective matched controlled study.
    Sharara AI; El-Halabi MM; Ghaith OA; Habib RH; Mansour NM; Malli A; El Hajj-Fuleihan G
    Metabolism; 2013 Apr; 62(4):518-26. PubMed ID: 23102518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.
    Fournier MR; Targownik LE; Leslie WD
    Maturitas; 2009 Sep; 64(1):9-13. PubMed ID: 19674854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2006 Aug; 79(2):76-83. PubMed ID: 16927047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease.
    Park JH; Lee J; Yu SY; Jung JH; Han K; Kim DH; Rhee J
    BMC Geriatr; 2020 Oct; 20(1):407. PubMed ID: 33059626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Proton pump inhibitors and their effect on the bone].
    Ječmenová M; Kroupa R
    Vnitr Lek; 2016 Feb; 62(2):139-46. PubMed ID: 27172441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fracture risk with PPIs and allergy to IV contrast.
    Dedea L
    JAAPA; 2010 Aug; 23(8):13. PubMed ID: 20821906
    [No Abstract]   [Full Text] [Related]  

  • 40. The relationship between proton pump inhibitor adherence and fracture risk in the elderly.
    Ding J; Heller DA; Ahern FM; Brown TV
    Calcif Tissue Int; 2014 Jun; 94(6):597-607. PubMed ID: 24706060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.